Stay updated on Fevipiprant PK in Hepatic Impairment vs Healthy Subjects Clinical Trial
Sign up to get notified when there's something new on the Fevipiprant PK in Hepatic Impairment vs Healthy Subjects Clinical Trial page.

Latest updates to the Fevipiprant PK in Hepatic Impairment vs Healthy Subjects Clinical Trial page
- Check5 days agoChange DetectedThe page now shows Revision: v3.5.0 as the latest version, replacing the previous Revision: v3.4.3.SummaryDifference0.1%

- Check12 days agoChange DetectedRevision: v3.4.3 replaces v3.4.2 on the page.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedA new Revision: v3.4.2 is added and a site-wide notice about government funding, along with the older Revision: v3.4.1, is removed, reflecting minor maintenance updates rather than changes to trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check48 days agoChange DetectedA site-wide notice about a lapse in government funding and the NIH Clinical Center status, along with a version update from v3.4.0 to v3.4.1, was added. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check55 days agoChange DetectedNew UI elements and external links were added, such as a glossary toggle and a plain-language trial summary reference, while core study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference43%

- Check69 days agoChange DetectedThe page shows Revision: v3.3.4 replacing v3.3.3; this is a minor site version update with no visible changes to study data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Fevipiprant PK in Hepatic Impairment vs Healthy Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fevipiprant PK in Hepatic Impairment vs Healthy Subjects Clinical Trial page.